We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
17:00 - 18:00
A6
Biomarkers of clinical response
Julius Fischer, Germany;
Kasper Kuna,
Mini-Orals
Clinical
17:00 - 18:00
Blood biomarkers in NSCLC stage III: results from the Austrian radio-oncologicaL Lung cancer STudy Association Registry (ALLSTAR)
Alexandra Hochreiter, Austria
-916
17:00 - 18:00
ST2 as a biomarker of late cardiotoxicity after adjuvant breast cancer radiotherapy: a six-year prospective follow-up study
Tanja Skyttä, Finland
-1904
17:00 - 18:00
Prediction of individual normal tissue radiosensitivity during radiotherapy for breast cancer patients, the role of genetic and inflammatory markers.
Mattias Hedman, Sweden
-3430
17:00 - 18:00
Prospective evaluation of longitudinal measurements of HPV ctDNA during chemoradiotherapy for anal squamous cell carcinoma
Daniel Martin, Germany
-2676
17:00 - 18:00
Longitudinal MRI assessment of glioblastoma response in the GOLD randomized trial of hypofractionated versus standard chemoradiation
Szabolcs David, The Netherlands
-1732